AFLAC Incorporated
Aflac Incorporated sells supplemental health and life insurance designed to pay cash benefits directly to policyholders when covered events occur, helping households manage out-of-pocket medical and income-disruption costs. The company operates through two core reporting segments—Aflac Japan and Aflac U.S.—and serves millions of policyholders in Japan and the United States. In the U.S., distribution is built around worksite/employee-benefits channels supported by a large agent and broker force, while Japan is centered on long-duration health and life products. Earnings and capital generation are tightly linked to underwriting performance (morbidity, mortality, persistency) and to investment portfolio results, including interest rates, credit spreads, and hedging outcomes.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueSupplemental health and life policies sold in Japan, supported by long-duration liabilities and investment portfolios.
U.S. worksite and voluntary benefits including accident, disability, critical care and hospital indemnity products.
Dental and vision offerings delivered through Aflac Benefits Solutions and employer benefits channels.
Supplemental life insurance products sold primarily through employer-related distribution.
Customers
Aflac’s end customers are individual policyholders who buy supplemental coverage to add cash benefits on top of major medical insurance, particularly to address deductibles, copays, and income gaps. In the U.S., purchasing is often mediated by employers and brokers in the worksite/employee-benefits channel, where Aflac’s agent force enrolls employees and services accounts. In Japan, customers typically purchase long-duration health and life products through local distribution partners and channels, with value tied to product features, premium rates, and claims service. Across both markets, persistency and claims experience (morbidity/mortality) are key drivers of customer economics and product pricing discipline.
Buy supplemental health and life policies for cash benefits and long-term protection; drives the majority of in-force liabilities and investment backing.
Purchase accident, disability, critical care and hospital indemnity through payroll/worksite enrollment to cover out-of-pocket medical and income risks.
Select Aflac offerings to broaden employee benefits and improve retention, enabling access to employee groups and enrollment events.
Distribute and service Aflac products; commissions and producer capacity influence sales momentum and account penetration.
Enroll in dental and vision plans administered through Aflac Benefits Solutions as part of employer-sponsored benefits.
Strategy
Aflac’s strategy centers on sustaining demand for supplemental products by competing on product features, premium rates, platforms, value-added services, and claims service, while leveraging brand awareness and distribution capabilities. In the U.S., management tracks agent productivity (weekly producer equivalents) as a leading indicator of sales capacity, reflecting a focus on distribution strength and enrollment execution. The company also emphasizes portfolio management and asset allocation—investing in fixed maturities, loan receivables, and growth assets (including public equities and limited partnership alternatives)—to support policy liabilities and earnings. Given competitive pressure from major medical carriers bundling and discounting supplemental products, Aflac’s differentiation relies on specialized supplemental design and service model rather than broad medical bundling. Ongoing investment and hedging activities are integral to managing yield, capital, and volatility across both segments.
Sales momentum depends on active producer capacity and enrollment execution in worksite channels.
Bundling/discounting by major medical carriers increases price and feature competition in supplemental segments.
Investment income and capital are key drivers of insurance economics and can be volatile with rates/spreads.
Geography
Aflac’s insurance operations are concentrated in two countries: Japan and the United States, reported as Aflac Japan and Aflac U.S. This geographic mix creates exposure to Japanese yen translation and to Japan-specific interest-rate dynamics, which management highlights through measures such as U.S. dollar-denominated investment income excluding foreign currency impact. The company also operates reinsurance activities including Aflac Re Bermuda Ltd., which is regulated under the Bermuda Insurance Act and has dividend and capital constraints. Geographic concentration means regulatory, competitive, and macro conditions in Japan and the U.S. can disproportionately affect sales, persistency, and investment results. The U.S. business is supported by a nationwide agent/broker footprint, while Japan is supported by local distribution and a large investment portfolio backing long-duration liabilities.
Risks
Aflac’s results are sensitive to market risks because large investment portfolios back policy liabilities; changes in interest rates and credit spreads can drive realized/unrealized gains and losses, impairments, and capital/dividend capacity at regulated subsidiaries. Competitive risk is elevated in the U.S. as major medical carriers seek entry into supplemental segments and use bundling and discounting to gain share, which can pressure pricing and persistency. The company disclosed a June 2025 cybersecurity incident involving exfiltration of sensitive personal and health information in its U.S. business, creating potential for remediation costs, litigation, regulatory actions, and reputational harm. As an insurer, Aflac also faces underwriting risks (morbidity, mortality, persistency) and regulatory constraints on intercompany transactions and subsidiary dividends. Concentration in Japan and the U.S. adds exposure to country-specific regulation, macro conditions, and foreign currency impacts on reported results.
- Cybersecurity incident with exfiltration of sensitive data (June 2025)Impact: CriticalLikelihood: High
May lead to remediation costs, higher insurance premiums, litigation, regulatory investigations/enforcement and reputational damage.
Exposure: U.S. claims/health/SSN and other personal data
- Interest rate risk on investment portfolios backing liabilitiesImpact: HighLikelihood: High
Significant rate changes can drive realized losses, impairments, unrealized swings and liquidity impacts, affecting results and capital.
Exposure: Large fixed income portfolios supporting policy liabilities
- Credit spread risk and market volatility affecting portfolio valuesImpact: HighLikelihood: Medium
Spread widening can create unrealized losses and reduce adjusted capital/dividend capacity; volatility complicates valuation.
Exposure: Credit investments and fair value marks
Accounting
Judgemental itemsMarket moves and valuation judgments can create large net investment gains/losses and affect capital.
Impact: Volatility in net earnings and shareholders’ equity
Assumptions on morbidity, mortality, persistency and discounting drive reserve levels.
Impact: Direct effect on insurance liabilities and earnings
Capitalization and amortization depend on expected profitability and persistency of policies.
Impact: Timing of expense recognition and segment profitability
Similar listed companies
Publicly listed companies with a comparable business focus.
Alphatec Holdings, Inc.
ATEC · Surgical & Medical Instruments & Apparatus
Abacus Global Management, Inc.
ABX · Investment Advice
Prudential Financial, Inc
PRU · Life Insurance
Prudential Financial is a U.S.-based financial services company organized around insurance, retirement, and investment management businesses.
Atlantic American Corporation
AAME · Life Insurance
Globe Life Inc
GL · Life Insurance
MetLife, Inc
MET · Life Insurance
MetLife is a U.S.-based insurance and financial services group that sells life insurance, annuities, employee benefits and retirement solutions, while also…
Last updated: 24/09/2026